APP and Alzheimer disease: Moreover, MN‐08 treatment enhanced the expression of α‐secretase (ADAM10) and Aβ‐degrading enzyme neprilysin (NEP), which accelerated the decomposition of Aβ and APP, increasing the levels of sAPPα in 3×Tg‐AD mice (Figure 3m,n).